指南与共识免疫规划卫生政策与健康促进

世界卫生组织关于使用分剂次黄热病疫苗的立场——2017年6月,对2013年6月《世界卫生组织黄热病疫苗立场文件》的补充

WHO position on the use of fractional doses - June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper - June 2013.
指南 / 共识 · Vaccine · 2017-07-06

本文摘录世界卫生组织(WHO)关于在黄热病疫苗供应短缺超出全球储备能力时使用分剂次黄热病疫苗的推荐,作为2013年立场文件的补充;2013年立场文件中的现有推荐不变。WHO于2016年10月由免疫策略咨询专家组(SAGE)讨论了这些推荐。

要点

  • 分剂次黄热病疫苗指按生产商推荐常规复溶后给予减少体积的疫苗剂量。
  • 该补充文件针对黄热病疫苗供应短缺超出全球储备能力的情况。
  • 2013年WHO黄热病疫苗立场文件中的现有推荐保持不变。

核心结论

  • 2013年WHO黄热病疫苗立场文件中的现有推荐保持不变。

研究设计与样本

  • 本文为WHO立场文件补充,摘录自2017年6月发布的《黄热病疫苗:WHO关于使用分剂次疫苗的立场——2017年6月,对2013年6月WHO黄热病疫苗立场文件的补充》。
  • 推荐由免疫策略咨询专家组(SAGE)于2016年10月讨论。

主要发现

  • 分剂次黄热病疫苗接种指按生产商推荐常规复溶后给予减少体积的疫苗剂量。
  • 该补充文件具体针对黄热病疫苗供应短缺超出全球储备能力的情况。

关键数值与推荐

  • 分剂次黄热病疫苗接种指按生产商推荐常规复溶后给予减少体积的疫苗剂量。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article presents the World Health Organization's (WHO) recommendations on the use of fractional doses of yellow fever vaccines excerpted from the "Yellow fever vaccine: WHO position on the use of fractional doses - June 2017, Addendum to Vaccines and vaccination against yellow fever WHO: Position Paper - June 2013″, published in the Weekly Epidemiological Record [1,2]. This addendum to the 2013 position paper pertains specifically to use of fractional dose YF (fYF) vaccination (fractional dose yellow fever vaccination refers to administration of a reduced volume of vaccine dose, which has been reconstituted as usual per manufacturer recommendations) in the context of YF vaccine supply shortages beyond the capacity of the global stockpile. The current WHO position on the use of yellow fever (YF) vaccine is set out in the 2013 WHO position paper on vaccines and vaccination against YF and those recommendations are unchanged. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of Yellow Fever vaccines were discussed by SAGE in October 2016; evidence presented at these meetings can be accessed at: www.who.int/immunization/sage/meetings/2016/October/presentations_background_docs/en/.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. World Health Organization. WHO position on the use of fractional doses - June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper - June 2013. Vaccine. 2017. PMID: 28689653. doi:10.1016/j.vaccine.2017.06.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。